Evidence map›Paper›PMID 32267606›Full record

ArticleCancer cytopathology2020

Cytologic grading of primary malignant salivary gland tumors: A blinded review by an international panel.

Daniel N Johnson, Mine Onenerk, Jeffrey F Krane, Esther Diana Rossi, Zubair Baloch, Güliz Barkan, Massimo Bongiovanni, Fabiano Callegari, Sule Canberk, Glen Dixon and 14 more

Abstract read
In one paragraph

Article in Cancer cytopathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Limitations of FNAC in detecting parotid malignancies: insights from a surgical cohort using the updated Milan System.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. The Critical Value of Telepathology in the COVID-19 Era.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2023
    Review
  7. Article
  8. Article
  9. Development of head and neck pathology in Europe.Virchows Archiv : an international journal of pathology · 2022
    Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Daniel N JohnsonDepartment of Pathology, Cytopathology Division, Northwestern University Feinberg School of Medicine, Chicago, Illinois.ORCID 0000-0002-1521-5368
Mine OnenerkGaziosmanpasa Training and Research Hospital, Istanbul, Turkey.
Jeffrey F KraneDepartment of Pathology, David Geffen School of Medicine at UCLA, Los Angeles, California.ORCID 0000-0001-7768-3901
Esther Diana RossiDepartment of Pathology, Fondazione Policlinico Universitario "Agostino Gemelli," IRCCS, Universita' Cattolica, Rome, Italy.ORCID 0000-0003-3819-4229
Zubair BalochDepartment of Pathology, University of Pennsylvania, Philadelphia, Pennsylvania.
Güliz BarkanLoyola University Healthcare System, Maywood, Illinois.ORCID 0000-0002-1825-4637
Massimo BongiovanniDepartment of Pathology, McGill University, Montreal, Quebec, Canada.ORCID 0000-0001-9846-6682
Fabiano CallegariUniversidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.
Sule CanberkCancer Signaling and Metabolism, Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal.
Glen DixonHCA Laboratories, HCA Healthcare UK, London, United Kingdom.
Andrew FieldDepartment of Pathology, St. Vincent Hospital, Sydney, Australia.
Christopher C GriffithCleveland Clinic Foundation, Cleveland, Ohio.ORCID 0000-0002-4407-6555
Nirag JhalaDepartment of Pathology and Laboratory Medicine, Temple University Hospital, Philadelphia, Pennsylvania.
Sara JiangDepartment of Pathology, Duke University Medical Center, Durham, North Carolina.ORCID 0000-0002-3069-3130
Daniel KurtyczDepartment of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, State Laboratory of Hygiene, Madison, Wisconsin.
Lester LayfieldDepartment of Pathology and Anatomical Services, University of Missouri, Columbia, Missouri.
Oscar LinDepartment of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York.ORCID 0000-0003-2089-6118
Zahra MalekiDivision of Cytopathology, Department of Pathology, The Johns Hopkins Hospital, Baltimore, Maryland.ORCID 0000-0003-3273-4802
Miguel Perez-MachadoDepartment of Cellular Pathology, Royal Free Hospital, London, United Kingdom.
Marc PusztaszeriDepartment of Pathology, McGill University, Montreal, Quebec, Canada.ORCID 0000-0001-6490-4189
Philippe VielhDepartment of Pathology, Laboratoire National de Santé, Dudelange, Luxembourg.
He WangDepartment of Pathology and Laboratory Medicine, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey.
Matthew A ZarkaDepartment of Pathology and Laboratory Medicine, Mayo Clinic, Scottsdale, Arizona.
William C FaquinDepartment of Pathology, Massachusetts General Hospital, Harvard School of Medicine, Boston, Massachusetts.ORCID 0000-0002-9043-7171

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Strategies to Overcome Immune Resistance in Head and Neck CancersP01CA240239 · NCI · YALE UNIVERSITY · PI MEMPEL, THORSTEN ROMAN · 2019 to 2023
$8.4M
NCI NIH HHS P01 CA240239NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

backgroundFine needle aspiration (FNA) is commonly used for the preoperative evaluation of salivary gland tumors. Tumor grade is a key factor influencing clinical management of salivary gland carcinomas (SGCs). To assess the ability to grade nonbasaloid SGCs in FNA specimens, an international panel of cytopathologists convened to review and score SGC cases.

methodsThe study cohort included 61 cases of primary SGC from the pathology archives of 3 tertiary medical centers. Cases from 2005 to 2016 were selected, scanned, and digitized. Nineteen cytopathologists blinded to the histologic diagnosis reviewed the digitized cytology slides and graded them as low, high, or indeterminate. The panelists' results were then compared to the tumor grades based on histopathologic examination of the corresponding resection specimens.

resultsAll but 2 of the 19 (89.5%) expert panelists review more than 20 salivary gland FNAs per year; 16 (84.2%) of the panelists work at academic medical centers, and 13 (68.4%) have more than 10 years' experience. Participants had an overall accuracy of 89.4% in the grading of SGC cases, with 90.2% and 88.3% for low- and high-grade SGC, respectively. Acinic cell carcinoma and mucoepidermoid carcinoma had the highest degree of accuracy, while epithelial-myoepithelial carcinoma and salivary duct carcinoma had the lowest degree of accuracy. As expected, the intermediate-grade SGC cases showed the greatest variability (high-grade, 42.1%; low-grade, 37.5%, indeterminate, 20.4%).

conclusionThis study confirms the high accuracy of cytomorphologic grading of primary SGC by FNA as low- or high-grade. However, caution should be exercised when a grade cannot be confidently assigned.

Indexed as

Biopsy, Fine-NeedleCohort StudiesCytodiagnosisHumansInternational CooperationNeoplasm GradingPathologistsPathology, ClinicalReproducibility of ResultsSalivary Gland NeoplasmsSalivary GlandsSensitivity and SpecificitycancercytologyFNAgradingMilan systemsalivary gland

Identifiers

PMID32267606
PMCPMC7413070

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.